Intech Investment Management LLC Bio Techne Corp Transaction History

Intech Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 18, 2024	SELL	$80.67 - $352.29 $275,246 - $1.2 Million	-3,412 Reduced 56.3%	2,648 $219,000
Q4 2022 Feb 09, 2023	SELL	$80.67 - $352.29 $275,246 - $1.2 Million	-3,412 Reduced 56.3%	2,648 $219,000
Q3 2022 Oct 18, 2024	BUY	$282.54 - $391.85 $1.71 Million - $2.37 Million	6,060 New	6,060 $1.72 Million
Q3 2022 Nov 10, 2022	BUY	$282.54 - $391.85 $1.53 Million - $2.12 Million	5,405 Added 825.19%	6,060 $1.72 Million
Q2 2022 Aug 10, 2022	BUY	$322.67 - $449.65 $211,348 - $294,520	655 New	655 $227,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.96B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intech Investment Management LLC with notifications on news.